Pharmacokinetics, metabolism and excretion of megazol in a Trypanosoma brucei gambiense primate model of human African trypanosomiasis - Preliminary study

Autor: Enanga, Bertin, Ndong, Jerôme Mezui Me, Boudra, Hamid, Debrauwer, Laurent, Dubreuil, Guy, Bouteille, Bernard, Chauviere, Gérard, Labat, Christian, Dumas, Michel, Perie, Jacques, Houin, Georges

Publikováno v: Arzneimittel-Forschung
Arzneimittel-Forschung, Thieme Publishing, 2000, 50 (2), pp.158-162. ⟨10.1055/s-0031-1300182⟩
Arzneimittel-Forschung, 2000, 50 (2), pp.158-162. ⟨10.1055/s-0031-1300182⟩

International audience; The pharmacokinetics of megazol (2-amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazol, CAS 19622-55-0) was investigated after a 100 mg/kg oral administration to six primates infected with Trypanosoma brucei gambiense. Th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::42edbb05fcdbe3ba640c9b970aedb8ec
https://hal.inrae.fr/hal-02699013